CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting

D G Courtney, J E Moore, Sarah Atkinson, E Maurizi, E H A Allen, D M L Pedrioli, W H I McLean, M. Andrew Nesbit, Tara Moore

Research output: Contribution to journalArticle

59 Citations (Scopus)

Fingerprint Dive into the research topics of 'CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting'. Together they form a unique fingerprint.

Medicine & Life Sciences